← Evidence map

ArticleFrontiers in pharmacology2024

Pharmacokinetics, safety, and efficacy of Fuqi Guben Gao in the treatment of kidney-yang deficiency syndrome: a randomized, double-blind phase I trial.

Wei-Yi Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39015370